Wagner J E, Broxmeyer H E, Cooper S
Department of Pediatrics (Divisions of Hematology/Oncology and Bone Marrow Transplantation), University of Minnesota School of Medicine, Minneapolis.
J Hematother. 1992 Summer;1(2):167-73. doi: 10.1089/scd.1.1992.1.167.
Human umbilical cord and placental blood is a rich source of hematopoietic stem cells that can be used to reconstitute hematopoiesis after intensive myeloablative therapy. Therefore, it has become necessary to develop techniques for (i) collecting large volumes of umbilical cord aseptically, (ii) optimizing the yield of viable cells after cryopreservation and thawing, and (iii) minimizing the risk of maternal T-cell contamination. Our protocol for the collection, cryopreservation, storage, and transport of human umbilical cord and placental blood is described in detail.
人脐带血和胎盘血是造血干细胞的丰富来源,可用于在强化清髓治疗后重建造血功能。因此,开发以下技术变得很有必要:(i)无菌采集大量脐带血;(ii)优化冷冻保存和解冻后活细胞的产量;(iii)将母体T细胞污染的风险降至最低。我们详细描述了人脐带血和胎盘血的采集、冷冻保存、储存和运输方案。